line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,190211826.189548,NEULANDLAB.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.248957,NEULANDLAB.NS
Normalized EBITDA,2025-03-31 00:00:00,3437691000.0,NEULANDLAB.NS
Total Unusual Items,2025-03-31 00:00:00,764036000.0,NEULANDLAB.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,764036000.0,NEULANDLAB.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,2601081000.0,NEULANDLAB.NS
Reconciled Depreciation,2025-03-31 00:00:00,655466000.0,NEULANDLAB.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,7505080000.0,NEULANDLAB.NS
EBITDA,2025-03-31 00:00:00,4201727000.0,NEULANDLAB.NS
EBIT,2025-03-31 00:00:00,3546261000.0,NEULANDLAB.NS
Net Interest Income,2025-03-31 00:00:00,-82971000.0,NEULANDLAB.NS
Interest Expense,2025-03-31 00:00:00,82971000.0,NEULANDLAB.NS
Interest Income,2025-03-31 00:00:00,,NEULANDLAB.NS
Normalized Income,2025-03-31 00:00:00,2027256826.189548,NEULANDLAB.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,2601081000.0,NEULANDLAB.NS
Total Expenses,2025-03-31 00:00:00,12191241000.0,NEULANDLAB.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,NEULANDLAB.NS
Diluted Average Shares,2025-03-31 00:00:00,12829639.0,NEULANDLAB.NS
Basic Average Shares,2025-03-31 00:00:00,12829639.0,NEULANDLAB.NS
Diluted EPS,2025-03-31 00:00:00,202.74,NEULANDLAB.NS
Basic EPS,2025-03-31 00:00:00,202.74,NEULANDLAB.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,2601081000.0,NEULANDLAB.NS
Net Income Common Stockholders,2025-03-31 00:00:00,2601081000.0,NEULANDLAB.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,NEULANDLAB.NS
Net Income,2025-03-31 00:00:00,2601081000.0,NEULANDLAB.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,2601081000.0,NEULANDLAB.NS
Net Income Continuous Operations,2025-03-31 00:00:00,2601081000.0,NEULANDLAB.NS
Tax Provision,2025-03-31 00:00:00,862209000.0,NEULANDLAB.NS
Pretax Income,2025-03-31 00:00:00,3463290000.0,NEULANDLAB.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,205093000.0,NEULANDLAB.NS
Special Income Charges,2025-03-31 00:00:00,764036000.0,NEULANDLAB.NS
Other Special Charges,2025-03-31 00:00:00,,NEULANDLAB.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-82971000.0,NEULANDLAB.NS
Total Other Finance Cost,2025-03-31 00:00:00,,NEULANDLAB.NS
Interest Expense Non Operating,2025-03-31 00:00:00,82971000.0,NEULANDLAB.NS
Interest Income Non Operating,2025-03-31 00:00:00,,NEULANDLAB.NS
Operating Income,2025-03-31 00:00:00,2577132000.0,NEULANDLAB.NS
Operating Expense,2025-03-31 00:00:00,4686161000.0,NEULANDLAB.NS
Other Operating Expenses,2025-03-31 00:00:00,1310647000.0,NEULANDLAB.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,655466000.0,NEULANDLAB.NS
Amortization,2025-03-31 00:00:00,,NEULANDLAB.NS
Depreciation Income Statement,2025-03-31 00:00:00,655466000.0,NEULANDLAB.NS
Selling General And Administration,2025-03-31 00:00:00,,NEULANDLAB.NS
Selling And Marketing Expense,2025-03-31 00:00:00,,NEULANDLAB.NS
General And Administrative Expense,2025-03-31 00:00:00,,NEULANDLAB.NS
Rent And Landing Fees,2025-03-31 00:00:00,,NEULANDLAB.NS
Gross Profit,2025-03-31 00:00:00,7263293000.0,NEULANDLAB.NS
Cost Of Revenue,2025-03-31 00:00:00,7505080000.0,NEULANDLAB.NS
Total Revenue,2025-03-31 00:00:00,14768373000.0,NEULANDLAB.NS
Operating Revenue,2025-03-31 00:00:00,14768373000.0,NEULANDLAB.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,0.0,NEULANDLAB.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.252487,NEULANDLAB.NS
Normalized EBITDA,2024-03-31 00:00:00,4751338000.0,NEULANDLAB.NS
Total Unusual Items,2024-03-31 00:00:00,0.0,NEULANDLAB.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,0.0,NEULANDLAB.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,3000789000.0,NEULANDLAB.NS
Reconciled Depreciation,2024-03-31 00:00:00,596999000.0,NEULANDLAB.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,7337967000.0,NEULANDLAB.NS
EBITDA,2024-03-31 00:00:00,4751338000.0,NEULANDLAB.NS
EBIT,2024-03-31 00:00:00,4154339000.0,NEULANDLAB.NS
Net Interest Income,2024-03-31 00:00:00,-139974000.0,NEULANDLAB.NS
Interest Expense,2024-03-31 00:00:00,139974000.0,NEULANDLAB.NS
Interest Income,2024-03-31 00:00:00,82268000.0,NEULANDLAB.NS
Normalized Income,2024-03-31 00:00:00,3000789000.0,NEULANDLAB.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,3000789000.0,NEULANDLAB.NS
Total Expenses,2024-03-31 00:00:00,11556909000.0,NEULANDLAB.NS
Rent Expense Supplemental,2024-03-31 00:00:00,9202000.0,NEULANDLAB.NS
Diluted Average Shares,2024-03-31 00:00:00,12829916.0,NEULANDLAB.NS
Basic Average Shares,2024-03-31 00:00:00,12829916.0,NEULANDLAB.NS
Diluted EPS,2024-03-31 00:00:00,233.89,NEULANDLAB.NS
Basic EPS,2024-03-31 00:00:00,233.89,NEULANDLAB.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,3000789000.0,NEULANDLAB.NS
Net Income Common Stockholders,2024-03-31 00:00:00,3000789000.0,NEULANDLAB.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,NEULANDLAB.NS
Net Income,2024-03-31 00:00:00,3000789000.0,NEULANDLAB.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,3000789000.0,NEULANDLAB.NS
Net Income Continuous Operations,2024-03-31 00:00:00,3000789000.0,NEULANDLAB.NS
Tax Provision,2024-03-31 00:00:00,1013576000.0,NEULANDLAB.NS
Pretax Income,2024-03-31 00:00:00,4014365000.0,NEULANDLAB.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,125443000.0,NEULANDLAB.NS
Special Income Charges,2024-03-31 00:00:00,0.0,NEULANDLAB.NS
Other Special Charges,2024-03-31 00:00:00,1199000.0,NEULANDLAB.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-139974000.0,NEULANDLAB.NS
Total Other Finance Cost,2024-03-31 00:00:00,29230000.0,NEULANDLAB.NS
Interest Expense Non Operating,2024-03-31 00:00:00,139974000.0,NEULANDLAB.NS
Interest Income Non Operating,2024-03-31 00:00:00,82268000.0,NEULANDLAB.NS
Operating Income,2024-03-31 00:00:00,4028896000.0,NEULANDLAB.NS
Operating Expense,2024-03-31 00:00:00,4218942000.0,NEULANDLAB.NS
Other Operating Expenses,2024-03-31 00:00:00,1051316000.0,NEULANDLAB.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,596999000.0,NEULANDLAB.NS
Amortization,2024-03-31 00:00:00,10558000.0,NEULANDLAB.NS
Depreciation Income Statement,2024-03-31 00:00:00,596999000.0,NEULANDLAB.NS
Selling General And Administration,2024-03-31 00:00:00,648530000.0,NEULANDLAB.NS
Selling And Marketing Expense,2024-03-31 00:00:00,339358000.0,NEULANDLAB.NS
General And Administrative Expense,2024-03-31 00:00:00,309172000.0,NEULANDLAB.NS
Rent And Landing Fees,2024-03-31 00:00:00,9202000.0,NEULANDLAB.NS
Gross Profit,2024-03-31 00:00:00,8247838000.0,NEULANDLAB.NS
Cost Of Revenue,2024-03-31 00:00:00,7337967000.0,NEULANDLAB.NS
Total Revenue,2024-03-31 00:00:00,15585805000.0,NEULANDLAB.NS
Operating Revenue,2024-03-31 00:00:00,15585805000.0,NEULANDLAB.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,6604541.821324,NEULANDLAB.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.242084,NEULANDLAB.NS
Normalized EBITDA,2023-03-31 00:00:00,2761971000.0,NEULANDLAB.NS
Total Unusual Items,2023-03-31 00:00:00,27282000.0,NEULANDLAB.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,27282000.0,NEULANDLAB.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,1635176000.0,NEULANDLAB.NS
Reconciled Depreciation,2023-03-31 00:00:00,527774000.0,NEULANDLAB.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,6137853000.0,NEULANDLAB.NS
EBITDA,2023-03-31 00:00:00,2789253000.0,NEULANDLAB.NS
EBIT,2023-03-31 00:00:00,2261479000.0,NEULANDLAB.NS
Net Interest Income,2023-03-31 00:00:00,-115108000.0,NEULANDLAB.NS
Interest Expense,2023-03-31 00:00:00,104015000.0,NEULANDLAB.NS
Interest Income,2023-03-31 00:00:00,15563000.0,NEULANDLAB.NS
Normalized Income,2023-03-31 00:00:00,1614498541.821324,NEULANDLAB.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,1635176000.0,NEULANDLAB.NS
Total Expenses,2023-03-31 00:00:00,9265571000.0,NEULANDLAB.NS
Rent Expense Supplemental,2023-03-31 00:00:00,8381000.0,NEULANDLAB.NS
Diluted Average Shares,2023-03-31 00:00:00,12829889.0,NEULANDLAB.NS
Basic Average Shares,2023-03-31 00:00:00,12829889.0,NEULANDLAB.NS
Diluted EPS,2023-03-31 00:00:00,127.45,NEULANDLAB.NS
Basic EPS,2023-03-31 00:00:00,127.45,NEULANDLAB.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,1635176000.0,NEULANDLAB.NS
Net Income Common Stockholders,2023-03-31 00:00:00,1635176000.0,NEULANDLAB.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,NEULANDLAB.NS
Net Income,2023-03-31 00:00:00,1635176000.0,NEULANDLAB.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,1635176000.0,NEULANDLAB.NS
Net Income Continuous Operations,2023-03-31 00:00:00,1635176000.0,NEULANDLAB.NS
Tax Provision,2023-03-31 00:00:00,522288000.0,NEULANDLAB.NS
Pretax Income,2023-03-31 00:00:00,2157464000.0,NEULANDLAB.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,5204000.0,NEULANDLAB.NS
Special Income Charges,2023-03-31 00:00:00,27282000.0,NEULANDLAB.NS
Other Special Charges,2023-03-31 00:00:00,-27282000.0,NEULANDLAB.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-115108000.0,NEULANDLAB.NS
Total Other Finance Cost,2023-03-31 00:00:00,26656000.0,NEULANDLAB.NS
Interest Expense Non Operating,2023-03-31 00:00:00,104015000.0,NEULANDLAB.NS
Interest Income Non Operating,2023-03-31 00:00:00,15563000.0,NEULANDLAB.NS
Operating Income,2023-03-31 00:00:00,2343414000.0,NEULANDLAB.NS
Operating Expense,2023-03-31 00:00:00,3127718000.0,NEULANDLAB.NS
Other Operating Expenses,2023-03-31 00:00:00,271293000.0,NEULANDLAB.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,527774000.0,NEULANDLAB.NS
Amortization,2023-03-31 00:00:00,12556000.0,NEULANDLAB.NS
Depreciation Income Statement,2023-03-31 00:00:00,515218000.0,NEULANDLAB.NS
Selling General And Administration,2023-03-31 00:00:00,594707000.0,NEULANDLAB.NS
Selling And Marketing Expense,2023-03-31 00:00:00,295793000.0,NEULANDLAB.NS
General And Administrative Expense,2023-03-31 00:00:00,298914000.0,NEULANDLAB.NS
Rent And Landing Fees,2023-03-31 00:00:00,8381000.0,NEULANDLAB.NS
Gross Profit,2023-03-31 00:00:00,5471132000.0,NEULANDLAB.NS
Cost Of Revenue,2023-03-31 00:00:00,6137853000.0,NEULANDLAB.NS
Total Revenue,2023-03-31 00:00:00,11608985000.0,NEULANDLAB.NS
Operating Revenue,2023-03-31 00:00:00,11608985000.0,NEULANDLAB.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,-4036081.916933,NEULANDLAB.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.223222,NEULANDLAB.NS
Normalized EBITDA,2022-03-31 00:00:00,1425443000.0,NEULANDLAB.NS
Total Unusual Items,2022-03-31 00:00:00,-18081000.0,NEULANDLAB.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,-18081000.0,NEULANDLAB.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,638220000.0,NEULANDLAB.NS
Reconciled Depreciation,2022-03-31 00:00:00,490402000.0,NEULANDLAB.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,5535020000.0,NEULANDLAB.NS
EBITDA,2022-03-31 00:00:00,1407362000.0,NEULANDLAB.NS
EBIT,2022-03-31 00:00:00,916960000.0,NEULANDLAB.NS
Net Interest Income,2022-03-31 00:00:00,-124994000.0,NEULANDLAB.NS
Interest Expense,2022-03-31 00:00:00,95335000.0,NEULANDLAB.NS
Interest Income,2022-03-31 00:00:00,9950000.0,NEULANDLAB.NS
Normalized Income,2022-03-31 00:00:00,652264918.083067,NEULANDLAB.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,638220000.0,NEULANDLAB.NS
Total Expenses,2022-03-31 00:00:00,8272438000.0,NEULANDLAB.NS
Rent Expense Supplemental,2022-03-31 00:00:00,7132000.0,NEULANDLAB.NS
Diluted Average Shares,2022-03-31 00:00:00,12829889.0,NEULANDLAB.NS
Basic Average Shares,2022-03-31 00:00:00,12829889.0,NEULANDLAB.NS
Diluted EPS,2022-03-31 00:00:00,49.74,NEULANDLAB.NS
Basic EPS,2022-03-31 00:00:00,49.74,NEULANDLAB.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,638220000.0,NEULANDLAB.NS
Net Income Common Stockholders,2022-03-31 00:00:00,638220000.0,NEULANDLAB.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,NEULANDLAB.NS
Net Income,2022-03-31 00:00:00,638220000.0,NEULANDLAB.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,638220000.0,NEULANDLAB.NS
Net Income Continuous Operations,2022-03-31 00:00:00,638220000.0,NEULANDLAB.NS
Tax Provision,2022-03-31 00:00:00,183405000.0,NEULANDLAB.NS
Pretax Income,2022-03-31 00:00:00,821625000.0,NEULANDLAB.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,4826000.0,NEULANDLAB.NS
Special Income Charges,2022-03-31 00:00:00,-18081000.0,NEULANDLAB.NS
Other Special Charges,2022-03-31 00:00:00,18081000.0,NEULANDLAB.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-124994000.0,NEULANDLAB.NS
Total Other Finance Cost,2022-03-31 00:00:00,39609000.0,NEULANDLAB.NS
Interest Expense Non Operating,2022-03-31 00:00:00,95335000.0,NEULANDLAB.NS
Interest Income Non Operating,2022-03-31 00:00:00,9950000.0,NEULANDLAB.NS
Operating Income,2022-03-31 00:00:00,960903000.0,NEULANDLAB.NS
Operating Expense,2022-03-31 00:00:00,2737418000.0,NEULANDLAB.NS
Other Operating Expenses,2022-03-31 00:00:00,261193000.0,NEULANDLAB.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,490402000.0,NEULANDLAB.NS
Amortization,2022-03-31 00:00:00,14809000.0,NEULANDLAB.NS
Depreciation Income Statement,2022-03-31 00:00:00,475593000.0,NEULANDLAB.NS
Selling General And Administration,2022-03-31 00:00:00,430945000.0,NEULANDLAB.NS
Selling And Marketing Expense,2022-03-31 00:00:00,274019000.0,NEULANDLAB.NS
General And Administrative Expense,2022-03-31 00:00:00,156926000.0,NEULANDLAB.NS
Rent And Landing Fees,2022-03-31 00:00:00,7132000.0,NEULANDLAB.NS
Gross Profit,2022-03-31 00:00:00,3698321000.0,NEULANDLAB.NS
Cost Of Revenue,2022-03-31 00:00:00,5535020000.0,NEULANDLAB.NS
Total Revenue,2022-03-31 00:00:00,9233341000.0,NEULANDLAB.NS
Operating Revenue,2022-03-31 00:00:00,9233341000.0,NEULANDLAB.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,NEULANDLAB.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,NEULANDLAB.NS
Normalized EBITDA,2021-03-31 00:00:00,,NEULANDLAB.NS
Total Unusual Items,2021-03-31 00:00:00,,NEULANDLAB.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,,NEULANDLAB.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,NEULANDLAB.NS
Reconciled Depreciation,2021-03-31 00:00:00,,NEULANDLAB.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,NEULANDLAB.NS
EBITDA,2021-03-31 00:00:00,,NEULANDLAB.NS
EBIT,2021-03-31 00:00:00,,NEULANDLAB.NS
Net Interest Income,2021-03-31 00:00:00,,NEULANDLAB.NS
Interest Expense,2021-03-31 00:00:00,,NEULANDLAB.NS
Interest Income,2021-03-31 00:00:00,16675000.0,NEULANDLAB.NS
Normalized Income,2021-03-31 00:00:00,,NEULANDLAB.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,NEULANDLAB.NS
Total Expenses,2021-03-31 00:00:00,,NEULANDLAB.NS
Rent Expense Supplemental,2021-03-31 00:00:00,7142000.0,NEULANDLAB.NS
Diluted Average Shares,2021-03-31 00:00:00,,NEULANDLAB.NS
Basic Average Shares,2021-03-31 00:00:00,,NEULANDLAB.NS
Diluted EPS,2021-03-31 00:00:00,,NEULANDLAB.NS
Basic EPS,2021-03-31 00:00:00,,NEULANDLAB.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,NEULANDLAB.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,NEULANDLAB.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,NEULANDLAB.NS
Net Income,2021-03-31 00:00:00,,NEULANDLAB.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,NEULANDLAB.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,NEULANDLAB.NS
Tax Provision,2021-03-31 00:00:00,,NEULANDLAB.NS
Pretax Income,2021-03-31 00:00:00,,NEULANDLAB.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,NEULANDLAB.NS
Special Income Charges,2021-03-31 00:00:00,,NEULANDLAB.NS
Other Special Charges,2021-03-31 00:00:00,2734000.0,NEULANDLAB.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,NEULANDLAB.NS
Total Other Finance Cost,2021-03-31 00:00:00,50978000.0,NEULANDLAB.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,NEULANDLAB.NS
Interest Income Non Operating,2021-03-31 00:00:00,16675000.0,NEULANDLAB.NS
Operating Income,2021-03-31 00:00:00,,NEULANDLAB.NS
Operating Expense,2021-03-31 00:00:00,,NEULANDLAB.NS
Other Operating Expenses,2021-03-31 00:00:00,,NEULANDLAB.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,NEULANDLAB.NS
Amortization,2021-03-31 00:00:00,12849000.0,NEULANDLAB.NS
Depreciation Income Statement,2021-03-31 00:00:00,,NEULANDLAB.NS
Selling General And Administration,2021-03-31 00:00:00,481215000.0,NEULANDLAB.NS
Selling And Marketing Expense,2021-03-31 00:00:00,346323000.0,NEULANDLAB.NS
General And Administrative Expense,2021-03-31 00:00:00,134892000.0,NEULANDLAB.NS
Rent And Landing Fees,2021-03-31 00:00:00,7142000.0,NEULANDLAB.NS
Gross Profit,2021-03-31 00:00:00,,NEULANDLAB.NS
Cost Of Revenue,2021-03-31 00:00:00,,NEULANDLAB.NS
Total Revenue,2021-03-31 00:00:00,,NEULANDLAB.NS
Operating Revenue,2021-03-31 00:00:00,,NEULANDLAB.NS
